TORONTO
,
Feb. 5
/CNW/ - DELISTING REVIEW - Bradmer Pharmaceuticals Inc. (the "Company") - Further to TSX Bulletin No. 2009-0904 dated
July 13, 2009
, TSX has determined to delist the common shares (Symbol: BMR) of the Company at the close of market on
March 5, 2010
for failure to meet the continued listing requirements of TSX.
About TMX Group
---------------
TMX Group's key subsidiaries operate cash and derivative markets for multiple asset classes including equities, fixed income and energy.
Toronto
Stock Exchange, TSX Venture Exchange,
Montreal
Exchange, Natural Gas Exchange,
Boston
Options Exchange (BOX), Shorcan, Equicom and other TMX Group companies provide trading markets, clearing facilities, data products and other services to the global financial community. TMX Group is headquartered in
Toronto
with offices in
Montreal
,
Calgary
and
Vancouver
. For more information about TMX Group, visit our website at www.tmx.com.
For further information: Corporate Communications, TMX Group Inc., Toll Free 1-888-873-8392, [email protected]
Share this article